Aplaviroc is a human cellular CC chemokine receptor 5 (CCR5) entry inhibitor. Aplaviroc binds specifically to CCR5 and demonstrates potent anti-human immunodeficiency virus activity in vitro in the subnanomolar range. In vitro studies show that aplaviroc selectively inhibits the binding of a particular monoclonal antibody, 45531, to CCR5.
Molecular Weight:
614.17
CAS Number:
[461023-63-2]
Formula:
C33H44ClN3O6
Target:
Others|||CCR|||HIV Protease
T26642
* VAT and and shipping costs not included. Errors and price changes excepted